To detect the most frequent chromosomal abnormalities at the early stages of pregnancy, screening approaches based on the analysis of fetal genetic material present in the maternal blood have been developed. The Non-Invasive Prenatal Testing (NIPT) is currently considered to be the expert screening that complements the conventional screening of the 1st trimester of pregnancy by making it more accurate due to the reduced number of false positive results.
The testing is performed beginning from the 10th week of pregnancy using the maternal venous blood as a test material.
The main advantages of Prenetix Non-Invasive Prenatal Testing are as follows:
(english speaking call center):
8 (800) 250-90-75